XML 37 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Schedule of Compensation Based Stock Option Activity

Compensation based stock option activity for qualified and unqualified stock options are summarized as follows:

 

          Weighted  
For the three months ended March 31, 2021         Average  
    Shares     Exercise Price  
Outstanding at January 1, 2021     3,941,301     $ 0.78  
Outstanding at March 31, 2021     3,941,301     $ 0.78  

 

For the year ended December 31, 2020

          Weighted  
          Average  
    Shares     Exercise Price  
Outstanding at January 1, 2020     6,145,044     $ 0.75  
Expired or canceled     (2,203,743 )     0.70  
Outstanding at December 31, 2020     3,941,301     $ 0.78  

Compensation based stock option activity for qualified and unqualified stock options for the years ended December 31, 2020 and 2019 are summarized as follows:

 

          Weighted  
For the year ended December 31, 2020         Average  
    Shares     Exercise Price  
Outstanding at January 1, 2020     6,145,044     $ 0.75  
Expired or cancelled     (2,203,743 )     0.70  
Outstanding at December 31, 2020     3,941,301     $ 0.78  

 

          Weighted  
For the year ended December 31, 2019         Average  
    Shares     Exercise Price  
Outstanding at January 2019     6,785,617     $ 0.75  
Expired or canceled     (640,573 )     0.62  
Outstanding at December 31, 2019     6,145,044     $ 0.75  

Schedule of Options to Purchase Shares of Common Stock Outstanding and Exercisable

The following table summarizes information about options to purchase shares of the Company’s Common Stock outstanding and exercisable at March 31, 2021:

 

                  Weighted-        
            Weighted-     Average        
      Outstanding     Average     Exercise     Number  
Exercise prices     Options     Remaining Life     Price     Exercisable  
                           
$ 0.22       1,750,000       7.22     $ 0.22       1,750,000  
  0.38       900,000       5.79       0.38       900,000  
  0.73       762,500       4.97       0.73       762,500  
  1.37       150,000       4.30       1.37       150,000  
  1.43       300,000       4.16       1.43       300,000  
  11.88       2,359       0.76       11.88       2,359  
  15.00       75,000       4.16       15.00       75,000  
  19.80       1,442       0.59       19.80       1,442  
          3,941,301       6.05     $ 0.78       3,941,301  

The following table summarizes information about options to purchase shares of the Company’s Common Stock outstanding and exercisable at December 31, 2020:

 

            Weighted-     Weighted-        
            Average     Average        
      Outstanding     Remaining Life     Exercise     Number  
Exercise prices     Options     In Years     Price     Exercisable  
                           
$ 0.22       1,750,000       7.47     $ 0.22       1,750,000  
  0.38       900,000       6.03       0.38       900,000  
  0.73       762,500       5.22       0.73       762,500  
  1.37       150,000       4.55       1.37       150,000  
  1.43       300,000       4.41       1.43       300,000  
  11.88       2,359       1.00       11.88       2,359  
  15.00       75,000       4.41       15.00       75,000  
  19.80       1,442       0.83       19.80       1,442  
          3,941,301       6.30     $ 0.78       3,941,301  

Schedule of Warrants Activity

The issuance of warrants to purchase shares of the Company’s Common Stock, including those attributed to debt issuances, as of March 31, 2021 and December 31, 2020 are summarized as follows:

 

          Weighted-  
          Average  
    Shares     Exercise Price  
Outstanding at January 1, 2021     18,702,500     $ 0.20  
Issued during three months ended March 31, 2021     2,035,000       0.20  
Outstanding at March 31, 2021     20,737,500     $ 0.20  

 

          Weighted-  
          Average  
For the year ended December 31, 2020   Shares     Exercise Price  
             
Outstanding at January 1, 2020     19,515,787     $ 0.60  
Issued during the year ended December 31, 2020     17,215,000       0.20  
Expired or cancelled     (18,028,287 )     0.63  
Outstanding at December 31, 2020     18,702,500     $ 0.20  

The issuance of warrants to purchase shares of the Company’s Common Stock, including those attributed to debt issuances, for the years ended December 31, 2020 and 2019, respectively are summarized as follows:

 

          Weighted-  
          Average  
For the year ended December 31, 2020   Shares     Exercise Price  
             
Outstanding at January 1, 2020     19,515,787     $ 0.60  
Issued during the year ended December 31, 2020     17,215,000       0.20  
Expired or cancelled     (18,028,287 )     0.63  
Outstanding at December 31, 2020     18,702,500     $ 0.20  

 

          Weighted-  
For the year ended December 31, 2019         Average  
    Shares     Exercise Price  
             
Outstanding at January 1, 2019     24,380,893     $ 1.05  
Expired or cancelled     (4,865,106 )     2.82  
Outstanding at December 31, 2019     19,515,787     $ 0.60  

Schedule of Warrants Outstanding and Exercisable

The following table summarizes information about warrants outstanding and exercisable at March 31, 2021:

 

    Outstanding and exercisable  
          Weighted-     Weighted-        
          Average     Average        
    Number     Remaining Life     Exercise     Number  
Exercise Price   Outstanding     in Years     Price     Exercisable  
                         
$ 0.20   1,487,500     2.08     $ 0.20     1,487,500  
  0.20     19,250,000       2.15       0.20       19,250,000  
        20,737,500       2.15     $ 0.20       20,737,500  

The following table summarizes information about warrants outstanding and exercisable at December 31, 2020:

 

      Outstanding and exercisable  
            Weighted-     Weighted-        
            Average     Average        
      Number     Remaining Life     Exercise     Number  
Exercise Price     Outstanding     in Years     Price     Exercisable  
                           
$ 0.20       1,487,500       2.50     $ 0.20       1,487,500  
  0.20       3,465,000       2.75-3.00       0.20       -  
  0.20       13,750,000       2.50       0.20       13,750,000  
                                     
          18,702,500       2.50     $ 0.20       15,237,500  

Schedule of Black Scholes Valuation Allowance Model of Warrants
Expected Term     3 years  
Expected volatility     140.5 %
Risk-free interest rates     1.40 %
Dividend yields     0.00 %

Expected Term     3 years  
Expected volatility     140.5 %
Risk-free interest rates     1.40 %
Dividend yields     0.00 %

Private Placement [Member]    
Schedule of Black Scholes Valuation Allowance Model of Warrants  
Expected Term     1.5 years  
Expected volatility     168.5%-191.9 %
Risk-free interest rates     0.13%-0.15 %
Dividend yields     0.00 %